IL10 and colitis: In one of the first in vitro studies on the IBD model, Hale et al. [123] showed that bromelain administered orally to mice caused both a decrease in the incidence and severity of spontaneous colitis and colonic inflammation in piroxicam-exposed IL-10-deficient mice (IL-10−/−) with established colitis.